Center for biologics evaluation and research (cber) requirement for biologics effectiveness and safety (best) initiative #3: health care data sources for surveillance of biologics (best 3)
Ended Awarded Last action
- Contract number
- 75F40125F19002
- Awardee
-
CVS Healthspire Payor & Life Sciences LLC UEI CNYSJ3KBMW97 Part of CVS Health Corporation
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $5,476,407
Award facts
- Opportunity
-
- 75F40125R00095 Solicitation number
- Contract value 100% obligated
- $5,476,406.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Time and Materials
- Place of performance
- Hartford, CT 06156, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $5,476,407 |
About this award
The Food and Drug Administration issued a delivery order to CVS Healthspire Payor & Life Sciences LLC on September 29, 2025, with a ceiling value of $5,476,406.69 under the CBER BEST Initiative 3 - Data Sources for Surveillance of Biologics IDIQ for healthcare data sources supporting post-market surveillance of biological drugs.
The parent IDIQ is a $50 million multiple-award FDA contract supporting the Biologics Effectiveness and Safety (BEST) Initiative through September 2029, providing healthcare data and safety analysis infrastructure. This delivery order is priced on a time and materials basis with an ultimate completion date of September 29, 2026. Place of performance is Hartford, CT. The order requires CVS Healthspire to deliver large-scale, longitudinal healthcare data covering millions of patients, including full medical chart access and safety analyses to support FDA's Center for Biologics Evaluation and Research surveillance mission.
Quick answers
Who was awarded contract 75F40125F19002?
75F40125F19002 was awarded to CVS Healthspire Payor & Life Sciences LLC by Food and Drug Administration (Department of Health and Human Services) on September 29, 2025.
How much is contract 75F40125F19002 worth?
The government has obligated $5,476,407 on 75F40125F19002.
Is contract 75F40125F19002 an order under another contract?
Yes. 75F40125F19002 is a delivery order under 75F40124D00042, an indefinite delivery contract, on CBER BEST Initiative 3 - Data Sources for Surveillance of Biologics.
Was contract 75F40125F19002 competed?
The extent of competition for 75F40125F19002 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award